Results 171 to 180 of about 212,870 (341)

Association of Tralokinumab and Adalimumab: Good Tolerance and Efficacy in a Case of Severe Atopic Dermatitis and Juvenile Idiopathic Arthritis

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Atopic dermatitis is a chronic inflammatory and pruritic skin disease. The combination of tralokinumab with adalimumab in the treatment of inflammatory diseases had not yet been documented. It appears promising for treating severe atopic dermatitis in patients with juvenile idiopathic arthritis, offering significant improvement in skin ...
F. Rakotonandrasana   +3 more
wiley   +1 more source

ERYTHEMA NODOSUM LEPROSUM

open access: bronze, 1959
A. R. DAVISON
openalex   +1 more source

The Complex Role of IL‐13 in Bullous Pemphigoid: New Insights From a Retrospective Cohort Study

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Background Bullous pemphigoid (BP) is the most common autoimmune blistering skin disease, primarily affecting the elderly. The role of interleukin‐13 (IL‐13) in BP pathogenesis remains unclear, particularly regarding its potential as a therapeutic target.
Marwan Dawood   +6 more
wiley   +1 more source

Reinfection with Borrelia Burgdorferi [PDF]

open access: yes, 1986
Ackermann   +14 more
core   +1 more source

Successful Treatment of Dupilumab in Two Cases of Refractory Kimura's Disease

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Kimura disease (KD) is a chronic inflammatory disorder characterized by subcutaneous nodules, cervical lymphadenopathy, hypereosinophilia, and elevated IgE levels. Treatment options are limited. We report two cases of refractory KD successfully treated with dupilumab.
Manon Blaise   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy